ERBB2 and cancer: By contrast, direct repeat amplification has been observed in cancer cells taken directly from patients, e.g., in esophageal adenocarcinoma bearing ERBB2 amplifications [41], and in gastric carcinoma bearing amplification of the 17q21 locus, which is not linked to common fragile sites [42].